Gina Shetty
Ophthalmology · Atlanta, GANPI 1457883860
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.8%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Rxsight Inc at 50.5% of the total. Reporting peaked in 2024 at $5,326 and has fallen 75.8% since, to $1,290 in 2025.
Across 111 payments — averaging $83.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rxsight Inc$5K
- Glaukos Corporation$757
- Johnson & Johnson Surgical Vision, Inc.$741
- Alcon$670
- Sun Pharmaceutical Industries Inc.$478
- Harrow Eye, LLC$466
- plus $1K from 12 others
What the payments were for
- Consulting fees$4,35047%
- Speaking & faculty fees$260%
- Food & beverage$4,88953%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rxsight Inc | 8 | $4,683 |
| Glaukos Corporation | 9 | $757 |
| Johnson & Johnson Surgical Vision, Inc. | 13 | $741 |
| Alcon | 22 | $670 |
| Sun Pharmaceutical Industries Inc. | 10 | $478 |
| Harrow Eye, LLC | 11 | $466 |
| Bausch & Lomb Americas Inc. | 8 | $301 |
| Sight Sciences, Inc. | 3 | $300 |
| Tarsus Pharmaceuticals, Inc. | 4 | $200 |
| Biotissue Holdings Inc. | 4 | $199 |
| Oyster Point Pharma, Inc. | 8 | $169 |
| Novartis | 4 | $109 |
| Johnson & Johnson Vision Care, Inc. | 1 | $58 |
| Revance Therapeutics, Inc. | 1 | $34 |
| Dompe US, Inc. | 2 | $34 |
| AbbVie | 1 | $25 |
| Amgen | 1 | $25 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RXSIGHT CONTACT LENS$4,350
- RXSIGHT INJECTOR CARTRIDGE$4,350
- RXSIGHT INJECTOR HANDPIECE$4,350
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$4,350
- LIGHT ADJUSTABLE LENS (LAL)$4,350
- VEVYE$265
- Photrexa Viscous and Photrexa$261
- Tecnis IOL$248
- CEQUA$224
- AcrySof IQ PanOptix$158
- CE-marked KXLA system$154
- OMNI(R) SURGICAL SYSTEM (US)$147
- Prokera$144
- AmnioGraft$144
- enVista MX60 IOL$138
- KXL System$137
- TearCare SmartLid$131
- TEARCARE(TM) (2.2) SYSTEM KIT$131
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$125
- TRYPTYR$109
How this compares
$9,264 in reported general payments places this provider in the 85th percentile of 481 ophthalmology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 41 | $1,160 |
| MoxifloxacinMoxifloxacin Hcl | 14 | $300 |
| Latanoprost | 43 | $174 |
| Brimonidine Tartrate | 13 | $160 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Atlanta
- Gagan SawhneyAtlanta$582K
- Lawrence WoodardAtlanta$578K
- Stephanie VanderveldtAtlanta$384K
- Steven YehAtlanta$289K
- Evan SchoenbergAtlanta$130K
- Robert StultingAtlanta$85K
- David SackelAtlanta$82K
- Atul SharmaAtlanta$77K
- Daniel MartinAtlanta$55K
- Douglas DayAtlanta$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.